Lee Financial CO Reata Pharmaceuticals Inc Transaction History

Lee Financial CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$19.41 - $36.49 $9,705 - $18,245	-500 Reduced 23.61%	1,618 $41,000
Q4 2021 Feb 08, 2022	SELL	$25.61 - $110.96 $14,469 - $62,692	-565 Reduced 21.06%	2,118 $56,000
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $20,169 - $28,421	-214 Reduced 7.39%	2,683 $267,000
Q3 2020 Nov 03, 2020	BUY	$93.53 - $163.34 $51,441 - $89,837	550 Added 23.43%	2,897 $282,000
Q1 2020 May 07, 2020	BUY	$124.16 - $247.74 $26,570 - $53,016	214 Added 10.03%	2,347 $339,000
Q2 2019 Jul 30, 2019	BUY	$77.72 - $94.35 $43,911 - $53,307	565 Added 36.03%	2,133 $201,000
Q3 2018 Nov 07, 2018	BUY	$35.64 - $92.06 $55,883 - $144,350	1,568 New	1,568 $128,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.